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HighlightsFor the first time, associated factors were assessed as predictors of ED‐state during COVID‐19 lockdown.Self‐directedness was associated with an aggravation of ED and general psychopathology during confinement.ED worsening was linked to less‐adaptive coping strategies in confinement situation with a resulting weight increase.

1. INTRODUCTION {#erv2771-sec-0005}
===============

The COVID‐19 disease has caused major disruptions across the world, after being declared as a pandemic by the World Health Organization (WHO) on 31rst January 2020 (WHO, [2020](#erv2771-bib-0040){ref-type="ref"}). The pandemic has led to a break with ordinary routines and social contact for most of the world\'s population. People with prior mental health disorders have been found to relapse during the pandemic (González‐Sanguino et al., [2020](#erv2771-bib-0016){ref-type="ref"}; Moccia et al., [2020](#erv2771-bib-0023){ref-type="ref"}; Ozamiz‐Etxebarria, Dosil‐Santamaria, Picaza‐Gorrochategui, & Idoiaga‐Mondragon, [2020](#erv2771-bib-0025){ref-type="ref"}; Rajkumar, [2020](#erv2771-bib-0028){ref-type="ref"}; Temorshuizen et al., [2020](#erv2771-bib-0032){ref-type="ref"}; Weissman et al., 2020). Hao et al. ([2020](#erv2771-bib-0019){ref-type="ref"}) found higher levels of concerns about their physical health, anger, anxiety, depression, impulsivity and intense suicidal ideation stress in psychiatric patients in comparison with healthy controls during COVID‐19 confinement. Moreover, evidence these effects may be long‐lasting (Shah et al., [2020](#erv2771-bib-0030){ref-type="ref"}).

Patients with eating disorders (ED) and/or obesity represent a vulnerable group (Cornejo‐Pareja, 2020;doi:10.1002/erv.2770 van Rensburg, [2020](#erv2771-bib-0035){ref-type="ref"}). Symptomatic deterioration such as purging, binging and exercise has been reported (Phillipou et al., [2020](#erv2771-bib-0027){ref-type="ref"}). Moreover the physical sequel of the disorders such as weight loss in anorexia nervosa (AN), electrolyte imbalance in bulimia nervosa (BN), or cardiovascular risk in binge eating disorder (BED) amplify the risk (Chew, Wei, Vasoo, Chua, & Sim, [2020](#erv2771-bib-0006){ref-type="ref"}; Fernández‐Aranda et al., [2020](#erv2771-bib-0012){ref-type="ref"}; Cornejo‐Pareja et al., 2020; Touyz, Lacey, & Hay, [2020](#erv2771-bib-0034){ref-type="ref"}). Also constraints in food supply chains may increase "food insecurity" (Temorshuizen et al., [2020](#erv2771-bib-0032){ref-type="ref"}; and increase food hoarding (Touyz et al., [2020](#erv2771-bib-0034){ref-type="ref"}) triggering bingeing (Fernández‐Aranda et al., [2020](#erv2771-bib-0012){ref-type="ref"}; Temorshuizen et al., [2020](#erv2771-bib-0032){ref-type="ref"}. Furthermore, emotional distress in the face of environmental changes is another triggering factor (Mediouni, Madiouni, & Kaczor‐Urbanowicz, [2020](#erv2771-bib-0022){ref-type="ref"}; Rodgers et al., [2020](#erv2771-bib-0029){ref-type="ref"}; Touyz et al., [2020](#erv2771-bib-0034){ref-type="ref"}; Clark‐Bryan et al., 2020;https://doi.org/10.1002/erv.2762 [2020](#erv2771-bib-0038){ref-type="ref"}). Restrictions placed on movement may have limited adaptive strategies in the face of these difficulties (Rodgers et al., [2020](#erv2771-bib-0029){ref-type="ref"}) with reduced access to support (Weissmann, Bauer, & Thomas [2020](#erv2771-bib-0033){ref-type="ref"}; Fernandez‐Aranda et al., 2020). Graell et al., 2020; https://doi.org/10.1002/erv.2763).

In the general population, factors related to the psychological impact include as female sex (González‐Sanguino et al., [2020](#erv2771-bib-0016){ref-type="ref"}; Özdin & Bayrak Özdin, [2020](#erv2771-bib-0026){ref-type="ref"}; Wang, Di, Ye, & Wei, [2020](#erv2771-bib-0037){ref-type="ref"}), low educational level and lower perceived health status (Özdin & Bayrak Özdin, [2020](#erv2771-bib-0026){ref-type="ref"}; Wang et al., [2020](#erv2771-bib-0037){ref-type="ref"}), and high perceived vulnerability to infection and exposure to news (Olagoke, Olagoke, & Hughes, [2020](#erv2771-bib-0024){ref-type="ref"}; Yao, [2020](#erv2771-bib-0041){ref-type="ref"}). Personality factors associated with better adaptation include higher scores in the fight‐flight system (related to personal safety concerns) and lower scores in the behavioural inhibition system (related to anxiety) (Bacon & Corr, [2020](#erv2771-bib-0003){ref-type="ref"}); confidence (linked to secure attachment) and discomfort with closeness (associated with avoidant attachment) (Moccia et al., [2020](#erv2771-bib-0023){ref-type="ref"}) and conscientiousness (Carvalho, Pianowski, & Gonçalves, [2020](#erv2771-bib-0005){ref-type="ref"}).

To the best of our knowledge, ours is the first study that examines the factors that might contribute to a poorer adaptation to the COVID‐19 pandemic.

1.1. Aims {#erv2771-sec-0006}
---------

The main aim of this study is to assess the factors that impact on the adjustment of people with ED to the COVID‐19 confinement. We hypothesized that that poorer social support and non‐adaptive coping strategies would be associated with a greater adverse reaction.

2. METHOD {#erv2771-sec-0007}
=========

2.1. Participants {#erv2771-sec-0008}
-----------------

The sample was constituted of 74 adults, with female predominance (71 patients, 95.9%) and a mean age of 32.12 (12.84) years old. They all were diagnosed with an ED and presented for treatment to the ED Unit within the Department of Psychiatry at a University Hospital in Spain: 19 AN, 12 BN, 10 BED and 33 Other Specified Feeding or Eating Disorder (OSFED). Patients were diagnosed according to DSM‐5 criteria (APA, [2013](#erv2771-bib-0002){ref-type="ref"}).

2.2. Procedure {#erv2771-sec-0009}
--------------

The present study was carried out in accordance with the latest version of the Declaration of Helsinki. The University Hospital Clinical Research Ethics Committee approved the study, and signed informed consent was obtained from all participants.

We used a semi‐structured telephone survey designed by a clinician team from our Unit, regarding five main thematic blocks to explore: (a) socio‐demographic information; (b) ED‐status; (c) COVID‐19 concerns; (d) pandemic stress (anxiety, depressive symptoms, other situations, and family conflicts) and, (e) coping strategies. This survey was administered as part of a prospective follow‐up coinciding with official COVID‐19 lockdown in the region of Catalonia (Spain) from 14th March to 11th May 2020 and was administered during April 2020.

2.3. Assessments {#erv2771-sec-0010}
----------------

### 2.3.1. Eating disorders inventory‐2 (EDI‐2) (Garner, [1991](#erv2771-bib-0013){ref-type="ref"}) {#erv2771-sec-0011}

It consists of 91 items self‐report questionnaire, answered on a 6‐point Likert scale, which assesses different cognitive and behavioural characteristics concerning ED: Drive for Thinness, Bulimia, Body Dissatisfaction, Ineffectiveness, Perfectionism, Interpersonal Distrust, Interoceptive Awareness, Maturity Fears, Asceticism, Impulse Regulation, and Social Insecurity. The EDI‐2 provides standardized subscale scores and a global measure of ED severity, which can be obtained based on the sum of all the items. The validated version for the Spanish population (Garner, [1998](#erv2771-bib-0014){ref-type="ref"}) had a mean internal consistency of 0.63 (coefficient alpha). Internal consistency for the total score in this study was between adequate (Cronbach‐alpha *α* = .70 for maturity fears) to excellent (*α* = .953 for total score).

### 2.3.2. Yale food addiction scale 2.0 (YFAS‐2) (Gearhardt, Corbin, & Brownell, [2016](#erv2771-bib-0015){ref-type="ref"}) {#erv2771-sec-0012}

It is a 35‐item self‐report questionnaire for measuring Food Addiction (FA) during the previous 12 months. It was based on the Diagnostic and Statistical Manual of Mental Disorders (DSM‐IV‐TR) (APA, [2000](#erv2771-bib-0001){ref-type="ref"}) criteria for substance dependence and was adapted to the context of food consumption. YFAS‐2, a newer version of the instrument, is based on DSM‐5 Criteria (APA, [2013](#erv2771-bib-0002){ref-type="ref"}) and evaluates 11 symptoms. Two measurements are shown: (a) a continuous symptom count score that reflects the number of fulfilled diagnostic criteria (ranging from 0 to 11), and (b) a FA food addiction threshold based on the number of symptoms (at least two) and self‐reported clinically significant impairment or distress. This final measurement allows for the binary classification of FA food addiction (present versus absent). Moreover, based on the revised DSM‐5 taxonomy, it is possible to establish severity cut‐offs: mild (between two and three symptoms), moderate (between four and five symptoms), and severe (between six and eleven symptoms). The Spanish validation of the YFAS‐2 (Granero et al., [2018](#erv2771-bib-0017){ref-type="ref"}) had an internal consistency of 0.94 (coefficient alpha). In this study, internal consistency for the total score was excellent (*α* = .949).

### 2.3.3. Symptom checklist‐90‐revised (SCL‐90‐R) (Derogatis, [1990](#erv2771-bib-0009){ref-type="ref"}) {#erv2771-sec-0013}

It consists of a 90‐item questionnaire that evaluates a broad range of psychological problems and symptoms of psychopathology by measuring nine primary symptom dimensions: Somatization, Obsession‐Compulsion, Interpersonal Sensitivity, Depression, Anxiety, Hostility, Phobic Anxiety, Paranoid Ideation, and Psychoticism. It also includes three global indices: global severity index (overall psychological distress), positive symptom distress index (the intensity of symptoms), and a positive symptom total (self‐reported symptoms). The global severity index can be used as a summary of the test. The validation of the scale in a Spanish population (Derogatis, [2002](#erv2771-bib-0010){ref-type="ref"}), obtained a mean internal consistency of .75 (coefficient alpha). The internal consistency for this study was between adequate (*α* = .763 for paranoid ideation) to excellent (*α* = .980 for global indexes).

### 2.3.4. Temperament and character inventory‐revised (TCI‐R) (Cloninger, Svrakic, Przybeck, & Whitehead, [1999](#erv2771-bib-0007){ref-type="ref"}) {#erv2771-sec-0014}

This questionnaire is composed of 240‐items scored on a 5‐point Likert scale and measures personality derived from three character dimensions (Self‐Directedness, Cooperativeness, and Self‐Transcendence) and four temperament scales (Harm Avoidance, Novelty Seeking, Reward Dependence and Persistence). Evaluation of the Spanish revised version (Gutiérrez‐Zotes et al., [2004](#erv2771-bib-0018){ref-type="ref"}) generated an internal consistency of 0.87 (coefficient alpha). The questionnaire obtained internal consistency in this study between moderate (*α* = .739 for cooperativeness) to excellent (*α* = .900 for harm avoidance).

### 2.3.5. Semi‐structured brief telephone survey during COVID‐19 confinement (Eating Disorders Unit, Psychiatry Department, University Hospital, Spain, 2020) {#erv2771-sec-0015}

First, sociodemographic information was up‐dated regarding lockdown period in terms of employment status, confinement compliance, affected environment by COVID‐19 and presence of company during this situation using dichotomous response (yes/no). The second part of the survey was related to ED‐state (measured as remaining equal, worsening, or remaining in the background). COVID‐19 concerns were classified as related to (a) own or family infection\'s risk and, (b) uncertain future, (c) employment status, (d) supply and access to treatments and, (e) other concerns. A yes /no evaluation of anxiety (psychical, emotional, motor, and cognitive dimensions), depressive symptoms (such as low mood, pessimism, or insomnia), other consequences (boredom or social conflicts) and familial conflicts were made. Finally, coping strategies during confinement were evaluated in two ways: (a) as presence or absence of both adaptive and non‐adaptive mechanisms and, (b) as well as the kind of strategies carried out by categorizing the coping mechanisms in dimensions (five for adaptive strategies: social contact; leisure; sports activities; daily routines; and academic/work activity and three dimensions for non‐adaptive ones: COVID‐19 over‐information; ED behaviours and other non‐adaptive behaviours. An extended version of this scale has been published in the current issue (Fernández‐Aranda et al., [2020](#erv2771-bib-0012){ref-type="ref"}).

2.4. Statistical analyses {#erv2771-sec-0016}
-------------------------

Statistical analysis was carried out with Stata16 for windows (Stata Press, [2019](#erv2771-bib-0031){ref-type="ref"}). The comparison between the groups of the study was done through chi‐square tests (*χ* ^2^) for categorical variables and *t* test for quantitative measures. Effect size for the proportion and the mean differences was estimated with Cohen\'s‐*d* coefficient, considering null effect for \|*d*\| \< 0.20, low‐poor for \|*d*\| \> 0.20, mild‐medium for \|*d*\| \> 0.50 and large‐high for \|*d*\| \> 0.80) (Cohen, [1988](#erv2771-bib-0008){ref-type="ref"}; Kelley & Preacher, [2012](#erv2771-bib-0020){ref-type="ref"}).

Path analysis procedure assessed the underlying relationships between the variables of the study (direct and indirect links, including mediational associations). This analysis was carried out as a case of structural equation modelling (SEM), with the maximum‐likelihood estimation method of parameter estimation. Due the large number of contextual and personal variables characterizing the COVID‐19 confinement, a latent variable was defined (labelled as "COVID" in the model, defined by the presence of concerns, adaptive reactions, non‐adaptive reactions, anxiety, depression, other problems and familiar conflicts). The goodness‐of‐fit was tested with standard statistical measures: *χ* ^2^ test, the root mean square error of approximation (RMSEA), Bentler\'s Comparative Fit Index (CFI), the Tucker‐Lewis Index (TLI), and the standardized root mean square residual (SRMR). Adequate fit was considered for (Barrett, [2007](#erv2771-bib-0004){ref-type="ref"}) non‐significant result in the *χ* ^2^ test, RMSEA\<0.08, TLI \> 0.90, CFI \> 0.90 and SRMR\<0.10.

3. RESULTS {#erv2771-sec-0017}
==========

3.1. Characteristics of the participants previous and during the confinement {#erv2771-sec-0018}
----------------------------------------------------------------------------

Coinciding with the lockdown, most patients were undergoing outpatient treatment (73 patients, 98.6%). Almost 27% (20 patients) of the sample were actively working, almost 95% (70 patients, 94.6%) had social support and only 17.6% (13 patients) had close people affected by COVID‐19.

The presence of concerns related with the confinement for COVID‐19 was reported by 52 patients (70.3%), a high prevalence of patients used adaptive reactions (*n* = 70, 94.6%), 19 patients (25.7%) also reported non‐adaptive reactions. The presence of anxiety symptoms was reported by 31 participants (41.9%) and depression by 22 (29.7%). Familial conflicts were noted by 15 individuals (20.3%) and other difficulties 34 patients (45.9%).

Symptom evolution during the confinement due to the COVID‐19, worsened in *n* = 19 patients (25.7%), and became less dominant in *n* = 38 (51.4). For this study, the participants were re‐classified in two groups based on the ED state during the confinement: symptom deterioration (*n* = 19) or not (*n* = 55).

3.2. Comparison of groups based on the ED progression during COVID‐19 lockdown {#erv2771-sec-0019}
------------------------------------------------------------------------------

No differences between these two groups were found for the marital status (*p* = .845), education levels (*p* = .796), social index (*p* = .555), and diagnostic subtype (*p* = .294) (see Table [S1](#erv2771-supitem-0001){ref-type="supplementary-material"}, supplementary material).

Table [1](#erv2771-tbl-0001){ref-type="table"} displays the comparisons between the groups of the study for the variables registered during the COVID‐19 lockdown. Patients who noticed an ED worsening reported higher prevalence of future concerns, such as access to medical treatment, non‐adaptive reactions, symptoms of anxiety and depression, adverse situations and familiar conflict.

###### 

Association between the ED‐state during the confinement with the measures registered during the COVID‐19

                                     Worse *n* = 19   Non‐worse *n* = 55                                                                  
  ---------------------------------- ---------------- -------------------- ---- ------ -------------------------------------------------- ---------------------------------------------------
  COVID‐related concerns             16               84.2                 36   65.5   .123                                               0.44
  Concerns: Infection risk           7                36.8                 14   25.5   .343                                               0.25
  Concerns: Uncertain future         10               52.6                 16   29.1   **.046** [\*](#erv2771-note-0001){ref-type="fn"}   **0.51** [^a^](#erv2771-note-0002){ref-type="fn"}
  Concerns: Employment               4                21.1                 11   20.0   .922                                               0.03
  Concerns: Medical treatments       4                21.1                 1    1.8    **.004** [\*](#erv2771-note-0001){ref-type="fn"}   **0.68** [^a^](#erv2771-note-0002){ref-type="fn"}
  Concerns: Other                    4                21.1                 6    10.9   .265                                               0.28
  Adaptive reactions                 17               89.5                 53   96.4   .252                                               0.28
  Adaptive reactions: Social         1                5.3                  13   23.6   .078                                               **0.55** [^a^](#erv2771-note-0002){ref-type="fn"}
  Adaptive reactions: Leisure        8                42.1                 34   61.8   .135                                               0.40
  Adaptive reactions: Sport          2                10.5                 15   27.3   .135                                               0.44
  Adaptive reactions: Routine        8                42.1                 34   61.8   .135                                               0.40
  Adaptive reactions: Work/studies   8                42.1                 14   25.5   .171                                               0.35
  Non‐adaptive reactions             10               52.6                 9    16.4   **.002** [\*](#erv2771-note-0001){ref-type="fn"}   **0.79** [^a^](#erv2771-note-0002){ref-type="fn"}
  Non‐adaptive reactions: COVID      1                5.3                  0    0.0    .575                                               0.46
  Non‐adaptive reactions: ED         5                26.3                 6    10.9   .104                                               0.40
  Non‐adaptive reactions: Other      4                21.2                 2    3.6    **.016** [\*](#erv2771-note-0001){ref-type="fn"}   **0.57** [^a^](#erv2771-note-0002){ref-type="fn"}
  Anxiety                            14               73.7                 17   30.9   **.001** [\*](#erv2771-note-0001){ref-type="fn"}   **0.89** [^a^](#erv2771-note-0002){ref-type="fn"}
  Anxiety: Physic                    6                31.6                 10   18.2   .221                                               0.31
  Anxiety: Emotional                 13               68.4                 14   25.5   **.001** [\*](#erv2771-note-0001){ref-type="fn"}   **0.89** [^a^](#erv2771-note-0002){ref-type="fn"}
  Anxiety: Motor                     6                31.6                 4    7.3    **.008** [\*](#erv2771-note-0001){ref-type="fn"}   **0.65** [^a^](#erv2771-note-0002){ref-type="fn"}
  Anxiety: Cognitive                 13               68.4                 11   20.0   **.001** [\*](#erv2771-note-0001){ref-type="fn"}   **1.02** [^a^](#erv2771-note-0002){ref-type="fn"}
  Depression                         12               63.2                 10   18.2   **.001** [\*](#erv2771-note-0001){ref-type="fn"}   **0.96** [^a^](#erv2771-note-0002){ref-type="fn"}
  Other situations                   13               68.4                 21   38.2   **.023** [\*](#erv2771-note-0001){ref-type="fn"}   **0.62** [^a^](#erv2771-note-0002){ref-type="fn"}
  Familiar conflicts                 8                42.1                 7    12.7   **.006** [\*](#erv2771-note-0001){ref-type="fn"}   **0.68** [^a^](#erv2771-note-0002){ref-type="fn"}

Bold: significant comparison.

Bold: effect size into the range mild--moderate (*\|d\|* \> 0.50) to high‐large (*\|d\|* \> 0.80).

Table [2](#erv2771-tbl-0002){ref-type="table"} compares the baseline assessment between the groups. Self‐directedness was lower in the group with deterioration in their ED symptoms: 117.4 versus 127.6; *p* = .048, \|*d*\| = 0.51).

###### 

Association between the ED‐state during the confinement with the clinical measures prior to the COVID‐19

                                       Worse *n = 19*   Non‐worse *n = 55*                                                                       
  ------------------------------------ ---------------- -------------------- -------- ------- -------------------------------------------------- ---------------------------------------------------
  Age (yrs‐old)                        32.53            13.60                31.98    12.69   .875                                               0.04
  Onset of the ED (yrs‐old)            16.42            4.22                 16.62    5.80    .892                                               0.04
  Duration of the ED (yrs)             14.49            11.56                14.60    11.32   .971                                               0.01
  EDI‐2: Drive for thinness            13.16            4.65                 12.42    6.68    .657                                               0.13
  EDI‐2: Body dissatisfaction          17.63            7.03                 14.80    8.24    .185                                               0.37
  EDI‐2: Interoceptive awareness       12.47            7.80                 10.44    6.72    .278                                               0.28
  EDI‐2: Bulimia                       6.26             4.63                 5.55     5.46    .610                                               0.14
  EDI‐2: Interpersonal distrust        6.16             4.82                 5.58     5.09    .668                                               0.12
  EDI‐2: Ineffectiveness               11.63            5.89                 9.98     7.36    .380                                               0.25
  EDI‐2: Maturity fears                7.42             5.49                 8.07     5.06    .637                                               0.12
  EDI‐2: Perfectionism                 4.84             3.47                 6.04     4.84    .326                                               0.28
  EDI‐2: Impulse regulation            6.89             4.48                 5.20     5.98    .263                                               0.32
  EDI‐2: Ascetic                       7.95             4.39                 6.89     4.93    .411                                               0.23
  EDI‐2: Social insecurity             7.68             4.99                 6.89     5.11    .559                                               0.16
  EDI‐2: Total score                   102.11           38.99                91.87    45.33   .383                                               0.24
  SCL‐90R: Somatization                1.49             0.98                 1.83     0.94    .189                                               0.35
  SCL‐90R: Obsess./compulsive          1.93             0.80                 1.87     0.82    .779                                               0.08
  SCL‐90R: Interpersonal sensitivity   2.03             0.95                 1.95     1.03    .757                                               0.08
  SCL‐90R: Depressive                  2.32             0.85                 2.15     1.01    .512                                               0.18
  SCL‐90R: Anxiety                     1.55             0.91                 1.59     0.97    .899                                               0.03
  SCL‐90R: Hostility                   1.65             1.21                 1.25     1.03    .167                                               0.36
  SCL‐90R: Phobic anxiety              0.86             0.86                 1.14     1.00    .281                                               0.30
  SCL‐90R: Paranoid ideation           1.34             0.65                 1.39     0.91    .837                                               0.06
  SCL‐90R: Psychotic                   1.29             0.87                 1.27     0.76    .909                                               0.03
  SCL‐90R: PST score                   1.70             0.77                 1.70     0.81    .997                                               0.00
  SCL‐90R: GSI score                   60.00            19.17                63.15    17.67   .515                                               0.17
  SCL‐90R: PSDI score                  2.42             0.57                 2.28     0.61    .373                                               0.24
  YFAS: Total score                    5.74             3.65                 5.58     3.69    .875                                               0.04
  TCI‐R: Novelty seeking               97.11            13.35                97.24    17.07   .976                                               0.01
  TCI‐R: Harm avoidance                117.53           18.34                115.51   21.90   .720                                               0.10
  TCI‐R: Reward dependence             103.53           14.30                101.33   17.95   .631                                               0.14
  TCI‐R: Persistence                   114.05           22.51                115.27   19.02   .819                                               0.06
  TCI‐R: Self‐directedness             117.37           20.96                127.56   18.70   **.048** [\*](#erv2771-note-0003){ref-type="fn"}   **0.51** [^a^](#erv2771-note-0004){ref-type="fn"}
  TCI‐R: Cooperativeness               133.89           9.69                 137.85   13.19   .234                                               0.34
  TCI‐R: Self‐transcendence            64.37            14.86                65.82    16.71   .739                                               0.09

Bold: significant comparison.

Bold: effect size into the range mild--moderate (*\|d\|* \> 0.50) to high‐large (*\|d\|* \> 0.80).

Table [S2](#erv2771-supitem-0002){ref-type="supplementary-material"} (supplementary material) contains the point‐serial correlation matrix with the associations between the variables measuring during the confinement with the clinical state registered previous to the COVID‐19 lockdown. The presence of concerns during the confinement was related to older age and lower EDI‐2 drive for thinness score. Non‐adaptive reactions were reported by patients with higher score in the YFAS‐2 scale, and depression symptoms were related to worse psychopathological state.

3.3. Path analysis {#erv2771-sec-0020}
------------------

Figure [1](#erv2771-fig-0001){ref-type="fig"} contains the path‐diagram with the standardized coefficients obtained in the SEM. Adequate fitting was obtained: *χ* ^2^ = 67.84 (*p* = .201), RMSEA = 0.045, CFI = 0.958, TLI = 0.945 and SRMR = 0.087.

![Path‐diagram with the standardized coefficients. *Note*. Continuous line: significant coefficient. Dash line: non‐significant coefficient](ERV-9999-na-g001){#erv2771-fig-0001}

The latent variable measuring the contextual and personal features during the COVID‐19 lockdown was associated with concerns related to the confinement, non‐adaptive reactions, anxiety, depression and familial conflicts. Results from the SEM suggest that a poorer state during the COVID‐19 lockdown and lower TCI‐R self‐directedness score increase the likelihood of deteriorating ED symptoms during the confinement (direct effects). The COVID‐19 latent variable was also a mediational variable in the model: indicating that age, self‐directedness and BMI, contributed indirectly to the deterioration in ED symptoms.

4. DISCUSSION {#erv2771-sec-0021}
=============

The present study explored the factors associated with symptomatic deterioration in people with ED. A quarter of patients became more symptomatic during lockdown a similar proportion to that found during the first weeks of confinement (Fernández‐Aranda et al., [2020](#erv2771-bib-0012){ref-type="ref"}). The deterioration was higher in people with AN followed by those with OSFED. This differential pattern aligns with other studies (Temorshuizen et al., [2020](#erv2771-bib-0032){ref-type="ref"}).

A novel feature of the present work was the association of symptom deterioration with low levels of self‐directedness. This aligns with other work in confinement Moccia et al. ([2020](#erv2771-bib-0023){ref-type="ref"}) and to the extensive literature associating in ED lower self‐directedness to poorer prognosis (Duffy et al., [2019](#erv2771-bib-0011){ref-type="ref"}; Krug et al., [2011](#erv2771-bib-0021){ref-type="ref"}). Age and ED severity, named drive for thinness (EDI‐2), were also related with COVID‐19 concerns. Patients with FA food addiction at baseline (Y‐FAS 2.0) had more non‐adaptive responses during COVID‐19 lockdown.

Finally, some strengths of this study should be highlighted. For instance, as the sample was comprised of patients who were linked to our unit before COVID‐19 outbreak, the baseline assessment was thorough. The use of a telephone interview rather than self‐report post COVID may have increased reliability. However, the sample size was modest and was without a control comparison.

5. CONCLUSIONS {#erv2771-sec-0022}
==============

In conclusion, the present findings suggest that an about a quarter of patient with an ED showed a deterioration in symptomatology, post COVID and this was mainly associated with lower self‐directedness. These results suggest the relevance of identifying specific vulnerability factors among ED patients in a confinement situation in order to develop preventive strategies and personalized treatment approaches.
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